Rankings
▼
Calendar
TMDX FY 2020 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena
TMDX
TransMedics Group, Inc.
$5B
FY 2020 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$26M
+8.6% YoY
Gross Profit
$17M
64.9% margin
Operating Income
-$26M
-102.9% margin
Net Income
-$29M
-112.1% margin
EPS (Diluted)
$-1.16
Cash Flow
Operating Cash Flow
-$30M
Free Cash Flow
-$31M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$152M
Total Liabilities
$48M
Stockholders' Equity
$104M
Cash & Equivalents
$25M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$26M
$24M
+8.6%
Gross Profit
$17M
$14M
+20.0%
Operating Income
-$26M
-$30M
+10.9%
Net Income
-$29M
-$34M
+14.3%
← Q4 2019
All Quarters
Q1 2020 →